IPRIPR2015-01340Final Written Decision
Mylan Pharmaceuticals Inc.v.AstraZeneca AB
IPR challenge of US RE44186.
Type
IPR
Filed
Jun 4, 2015
Instituted
May 2, 2016
Decided
—
Patent
Application
13308658
Inventor
Jeffrey A. Robl et al
Granted
Apr 30, 2013
01
Timeline
3 milestones
2015-06-04Petition filed
2016-05-02Institution
2017-08-18Terminated
02
Parties & counsel
Petitioner
Mylan Pharmaceuticals Inc.
Counsel
Parmelee, Stevenet al
Patent Owner
AstraZeneca AB
Counsel
Lipsey, Charleset al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →